Chorea and seizures in a patient with a rare VPS13A gene mutation and neuroacanthocytosis

Vignesh Anapathur Srinivasan1, Jeevitha Moorthy1, Kanagasabai Kamalasekar2

  • 1Neurology, Kauvery Hospital Chennai, Chennai, Tamil Nadu, India.

BMJ Case Reports
|October 17, 2025
PubMed

Insights

Choreo-acanthocytosis, a rare neurodegenerative disorder, is detailed in this case report. Genetic testing identified a VPS13A mutation, highlighting the importance of genetic analysis for atypical movement disorders.

Area of Science:

  • Neurogenetics
  • Movement Disorders
  • Neurodegenerative Diseases

Background:

  • Choreo-acanthocytosis (hAc) is an autosomal-recessive neurodegenerative disorder.
  • It typically presents with movement abnormalities, seizures, and behavioral changes.

Purpose of the Study:

  • To report a case of Choreo-acanthocytosis in a male patient with progressive movement disorder, seizures, and cognitive decline.
  • To emphasize the diagnostic challenges, differential diagnoses, and the role of genetic testing in atypical movement disorders.
  • To expand the understanding of the VPS13A gene's mutational spectrum and clinical variability.

Main Methods:

  • Clinical case presentation.
  • Neurological examination and neuroimaging.
  • Routine metabolic and infectious investigations.
  • Genetic testing for VPS13A variants.

Main Results:

  • The patient exhibited progressive movement disorder, seizures, and cognitive impairment.
  • Neuroimaging suggested basal ganglia degeneration.
  • Genetic analysis revealed a likely pathogenic VPS13A variant (c.799C>T, p.Arg267Ter).

Conclusions:

  • This case underscores the complexity of diagnosing Choreo-acanthocytosis.
  • Genetic testing is crucial for identifying rare mutations like VPS13A in atypical movement disorders.
  • The VPS13A mutation significantly impacts patient quality of life and expands the known clinical presentations of hAc.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
814
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
693
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K